首页> 外文OA文献 >A one-year prospective, randomized, placebo-controlled, quadruple-blinded, phase II safety pilot trial of combination therapy with interferon beta-1a and mycophenolate mofetil in early relapsing-remitting multiple sclerosis (TIME MS).

【2h】

A one-year prospective, randomized, placebo-controlled, quadruple-blinded, phase II safety pilot trial of combination therapy with interferon beta-1a and mycophenolate mofetil in early relapsing-remitting multiple sclerosis (TIME MS).

机译：一项为期一年的前瞻性，随机，安慰剂对照，四盲，II期安全性先导试验，与干扰素β-1a和霉酚酸酯联用治疗早期复发-缓解型多发性硬化症（TIME MS）。

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
G. M. Remington; K. Treadaway; T. Frohman; A. Salter; O. Stüve; M. K. Racke; K. Hawker; F. Agosta; M. P. Sormani; M. Filippi; E. M. Frohman;
展开▼
作者单位

展开▼
年度 2010
总页数
原文格式 PDF
正文语种 eng
中图分类

相似文献

外文文献
中文文献

1. A one-year prospective, randomized, placebo-controlled, quadruple-blinded, phase II safety pilot trial of combination therapy with interferon beta-1a and mycophenolate mofetil in early relapsing-remitting multiple sclerosis (TIME MS). [J] . Remington GM, Treadaway K, Frohman T, Therapeutic advances in neurological disorders. . 2010,第1期

机译：一项为期一年的前瞻性，随机，安慰剂对照，四盲，II期安全性先导性试验，与干扰素β-1a和霉酚酸酯联用治疗早期复发-缓解型多发性硬化症（TIME MS）。
2. A one-year prospective, randomized, placebo-controlled, quadruple-blinded, phase II safety pilot trial of combination therapy with interferon beta-1a and mycophenolate mofetil in early relapsing—remitting multiple sclerosis (TIME MS) [J] . Remington Gina M., Treadaway Katherine, Frohman Teresa, Therapeutic advances in neurological disorders. . 2010,第1期

机译：一项为期一年的前瞻性，随机，安慰剂对照，四盲，II期安全性早期试验，在早期复发-缓解多发性硬化症（TIME MS）中联合应用干扰素β-1a和霉酚酸酯治疗
3. A randomized, blinded, parallel-group, pilot trial of mycophenolate mofetil (CellCept) compared with interferon beta-1a (Avonex) in patients with relapsing-remitting multiple sclerosis. [J] . Frohman EM, Cutter G, Remington G, Therapeutic advances in neurological disorders. . 2010,第1期

机译：霉酚酸酯（CellCept）与干扰素β-1a（Avonex）在复发缓解型多发性硬化症患者中进行的随机，盲法，平行组，先导性试验。
4. A one-year prospective randomized placebo-controlled quadruple-blinded phase II safety pilot trial of combination therapy with interferon beta-1a and mycophenolate mofetil in early relapsing–remitting multiple sclerosis (TIME MS) [O] . Gina M. Remington, Katherine Treadaway, Teresa Frohman, 2010

机译：一项为期一年的前瞻性随机安慰剂对照四盲II期安全性早期试验联合干扰素β-1a和霉酚酸酯在早期复发-缓解的多发性硬化症（TIME MS）中联合使用
5. A one-year prospective, randomized, placebo-controlled, quadruple-blinded, phase II safety pilot trial of combination therapy with interferon beta-1a and mycophenolate mofetil in early relapsing–remitting multiple sclerosis (TIME MS) [O] . Remington, Gina M., Treadaway, Katherine, Frohman, Teresa, 2010

机译：一项为期一年的前瞻性，随机，安慰剂对照，四盲，II期安全性早期试验，联合干扰素β-1a和霉酚酸酯在早期复发-缓解的多发性硬化症（TIME MS）中联合使用

A one-year prospective, randomized, placebo-controlled, quadruple-blinded, phase II safety pilot trial of combination therapy with interferon beta-1a and mycophenolate mofetil in early relapsing-remitting multiple sclerosis (TIME MS).

著录项

相似文献

相关主题

期刊订阅